Skip to main content
TipRanks
Go Ultimate75% OFF

Atea Pharmaceuticals (AVIR) Ratios

248 Followers

Atea Pharmaceuticals Ratios

AVIR's free cash flow for Q3 2026 was $-28.87M. For the 2026 fiscal year, AVIR's free cash flow was increased by $0.00 and operating cash flow was $-28.87M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio7.8224.8518.2435.7713.58
Quick Ratio7.8224.8518.2435.7713.58
Cash Ratio2.413.484.4435.0013.44
Solvency Ratio-3.97-6.51-3.41-4.421.93
Operating Cash Flow Ratio-3.32-7.28-2.64-6.55-1.53
Short-Term Operating Cash Flow Coverage-156.620.000.000.000.00
Net Current Asset Value$ 271.21M$ 436.55M$ 550.68M$ 634.79M$ 709.59M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.141.061.071.041.09
Debt Service Coverage Ratio-187.350.000.00-9.620.00
Interest Coverage Ratio0.000.000.00-11.720.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.010.020.030.170.00
Net Debt to EBITDA0.580.481.185.81-5.52
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%52.41%
EBIT Margin0.00%0.00%0.00%0.00%39.38%
EBITDA Margin0.00%0.00%0.00%0.00%39.39%
Operating Profit Margin0.00%0.00%0.00%0.00%39.38%
Pretax Profit Margin0.00%0.00%0.00%0.00%39.44%
Net Profit Margin0.00%0.00%0.00%0.00%34.49%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%34.49%
Net Income Per EBT96.25%100.55%100.75%97.00%87.44%
EBT Per EBIT90.95%86.79%82.20%91.46%100.15%
Return on Assets (ROA)-50.23%-36.24%-22.85%-17.39%15.68%
Return on Equity (ROE)-57.49%-38.37%-24.49%-18.09%17.07%
Return on Capital Employed (ROCE)-65.67%-43.26%-29.18%-20.15%19.33%
Return on Invested Capital (ROIC)-63.02%-43.18%-29.14%-19.53%16.90%
Return on Tangible Assets-50.23%-36.24%-22.85%-17.39%15.68%
Earnings Yield-54.43%-59.65%-53.45%-28.95%16.37%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.0018.7016.4824.4636.88
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.001909.60
Asset Turnover0.000.000.000.000.45
Working Capital Turnover Ratio0.000.000.000.000.56
Cash Conversion Cycle0.00-19.52-22.14-14.92-9.90
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.0019.5222.1414.929.90
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.62-1.61-1.02-1.45-1.05
Free Cash Flow Per Share-1.62-1.61-1.02-1.48-1.05
Dividend Paid and CapEx Coverage Ratio0.000.000.00-62.27-21751.25
Capital Expenditure Coverage Ratio0.000.000.00-62.27-21751.25
Operating Cash Flow Coverage Ratio-156.62-82.52-35.55-38.73-441.65
Operating Cash Flow to Sales Ratio0.000.000.000.00-0.25
Free Cash Flow Yield-45.38%-48.00%-33.58%-30.70%-11.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.84-1.68-1.87-3.456.11
Price-to-Sales (P/S) Ratio0.000.000.000.002.11
Price-to-Book (P/B) Ratio1.060.640.460.631.04
Price-to-Free Cash Flow (P/FCF) Ratio-2.20-2.08-2.98-3.26-8.51
Price-to-Operating Cash Flow Ratio-2.20-2.08-2.98-3.31-8.51
Price-to-Earnings Growth (PEG) Ratio0.61-0.07-0.110.02-0.00
Enterprise Value Multiple-1.19-1.66-0.942.19-0.17
Enterprise Value196.07M219.23M112.92M-243.17M-23.77M
EV to EBITDA-1.19-1.66-0.942.19-0.17
EV to Sales0.000.000.000.00-0.07
EV to Free Cash Flow-1.49-1.62-1.321.980.27
EV to Operating Cash Flow-1.49-1.62-1.322.010.27
Tangible Book Value Per Share3.385.216.667.698.57
Shareholders’ Equity Per Share3.385.216.667.698.57
Tax and Other Ratios
Effective Tax Rate0.04-0.01-0.010.030.13
Revenue Per Share0.000.000.000.004.24
Net Income Per Share-1.94-2.00-1.63-1.391.46
Tax Burden0.961.011.010.970.87
Interest Burden1.001.271.121.081.00
Research & Development to Revenue0.000.000.000.000.48
SG&A to Revenue0.000.000.000.000.13
Stock-Based Compensation to Revenue0.000.000.000.000.11
Income Quality0.830.800.631.04-0.72

Currency in USD